Trial Profile

Phase III trial of esflurbiprofen (TT-063) analgesic patch in Japanese patients with osteoarthritis of the knee

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 31 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Esflurbiprofen (Primary) ; Flurbiprofen
Indications Osteoarthritis
Focus Registrational; Therapeutic Use
Sponsors Taisho Pharmaceutical

Most Recent Events

22 Jul 2015 According to Taisho Pharmaceuticals media release, company has announced two results at the Annual Meeting of the Japanese Clinical Orthopaedic Association.
21 Jul 2015 Results published in Taisho Pharmaceutical media release.
01 Apr 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com